Zydus Pharmaceuticals recalled 4,440 bottles of Entecavir Tablets on September 4, 2025. The recall follows failure to meet impurity and degradation specifications. Consumers should stop using the affected tablets immediately and contact their healthcare provider.
Failed Impurity/Degradation Specifications
Consumers and healthcare providers should stop using this product immediately. Contact Zydus Pharmaceuticals (USA) Inc or your healthcare provider for guidance. Notification method: N/A
The recall affects Entecavir Tablets, USP, 1 mg, in 30-tablet bottles. The affected lot number is E309377, with an expiration date of November 30, 2025. The product was distributed nationwide in the United States.
The recall is due to failure to meet impurity and degradation specifications. This could potentially compromise the quality and efficacy of the medication.
There are no reported incidents of injury or adverse effects associated with this recall. The recall is conducted as a precautionary measure.
Stop using the recalled Entecavir Tablets immediately. Contact Zydus Pharmaceuticals (USA) Inc. or your healthcare provider for guidance and further information.
For additional information, consumers can contact Zydus Pharmaceuticals at 1-XXX-XXX-XXXX or visit their website.
Glenmark Pharmaceuticals Inc. recalled 13,824 tubes of Azelaic Acid Gel on September 17, 2025. The recall stems from market complaints regarding a gritty texture. Consumers should stop using the product immediately and contact their healthcare provider.
Skin MD by Dr Monika Kiripolsky recalled its Body Acne Cleanser on September 12, 2025. The recall follows the discovery of elevated benzene levels in the product. This contamination poses a high health risk to consumers in California and Georgia.
Private Label Skin Care recalled its Micronized BPO Gel Cleanser 10% on September 12, 2025. Elevated benzene levels prompted the recall in California and Georgia. Consumers must stop using the product immediately and seek guidance from healthcare providers.